Microglia have been revealed to first help spread Alzheimer’s disease pathology across the brain and then activate to limit ...

As the year comes to a close, experts from the Alzheimer's Association reflect on some of the hopeful advances in diagnosis, ...

The once-monthly injection is intended for adults with early symptomatic Alzheimer’s disease. This is the first medication to ...

There's still so much we don't know about Alzheimer's disease, but the link between poor sleep and worsening disease is one ...

Cedar Valley Clinical Research in Waterloo is seeking participants for a clinical study of an investigational medication for ...

In a year plagued by the challenges of Alzheimer's disease, 2024 brought a glimmer of hope with the approval of the third new ...

The active genes in the body have to be copied, or transcribed into RNA molecules, which are then processed in a variety of ...

2024 — A loss of brain volume associated with new immunotherapies for Alzheimer's disease may be caused by the removal of amyloid plaques, rather than the loss of neurons or brain tissue ...

Even as new drugs come to market, further study appears to point to infections as a possible cause for the debilitating ...